Merck's 2026 Reorganization — Oncology vs. Specialty/Pharma/Infectious Diseases, and Why It Matters for Your Role

On February 23, 2026, Merck announced one of the biggest reorganizations in its history — splitting Human Health into a standalone Oncology unit and a Specialty/Pharma/Infectious Diseases unit. This module explains the structure, the leaders (Jannie Oosthuizen and Brian Foard), and why interviewers will care that you understand it.